TEVA vs. MRK
Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TEVA or MRK.
Correlation
The correlation between TEVA and MRK is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
TEVA vs. MRK - Performance Comparison
Key characteristics
TEVA:
0.84
MRK:
-1.16
TEVA:
1.72
MRK:
-1.49
TEVA:
1.22
MRK:
0.79
TEVA:
0.45
MRK:
-0.85
TEVA:
5.97
MRK:
-1.79
TEVA:
6.18%
MRK:
14.65%
TEVA:
44.15%
MRK:
22.67%
TEVA:
-90.80%
MRK:
-68.62%
TEVA:
-74.53%
MRK:
-30.75%
Fundamentals
TEVA:
$19.33B
MRK:
$229.54B
TEVA:
-$1.43
MRK:
$4.78
TEVA:
1.05
MRK:
0.07
TEVA:
$16.56B
MRK:
$48.59B
TEVA:
$8.07B
MRK:
$36.68B
TEVA:
$480.00M
MRK:
$19.73B
Returns By Period
In the year-to-date period, TEVA achieves a -22.60% return, which is significantly lower than MRK's -8.79% return. Over the past 10 years, TEVA has underperformed MRK with an annualized return of -10.74%, while MRK has yielded a comparatively higher 8.20% annualized return.
TEVA
-22.60%
-19.68%
0.89%
37.80%
7.11%
-10.74%
MRK
-8.79%
-8.47%
-17.16%
-26.12%
5.30%
8.20%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TEVA vs. MRK — Risk-Adjusted Performance Rank
TEVA
MRK
TEVA vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
TEVA vs. MRK - Dividend Comparison
TEVA has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 3.44%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.07% | 2.38% |
MRK Merck & Co., Inc. | 3.44% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
Drawdowns
TEVA vs. MRK - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.80%, which is greater than MRK's maximum drawdown of -68.62%. Use the drawdown chart below to compare losses from any high point for TEVA and MRK. For additional features, visit the drawdowns tool.
Volatility
TEVA vs. MRK - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 17.02% compared to Merck & Co., Inc. (MRK) at 11.11%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
TEVA vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities